Anesthesiology & Pain Management

Shelter Medicine

Animal Welfare

Aquatic Medicine

Poultry Medicine

Avian & Exotic

Behavior

Dentistry

Dermatology

Emergency & Critical Care

Equine Medicine

Feline Medicine

Geriatric & Palliative Medicine

Infectious Diseases & Epidemiology

Integrative & Holistic Medicine

Cardiology

Diabetes

Endocrinology

Gastroenterology

Neurology

Oncology

Respiratory Medicine

Urology/Nephrology

Internal Medicine

Food Animals

Small Ruminant

Swine

Livestock

Microbiome

Nutrition

One Health

Ophthalmology

Orthopedics

Parasitology

Pathology

Pediatrics

Pharmacology

Preventive Medicine

Radiology

Rehabilitation

Surgery

Theriogenology

Toxicology

Virtual Care

Zoo Medicine

News

All News

Breaking News

Conference News

Expert Interviews

Programs

dvm360 Insights

dvm360 LIVE!

Pet Connections

Product360

The Vet Blast Podcast

Vet Perspectives™

VetXchange®

Vet Watch

dvm360IQ

Fetch

All Conferences

Kansas City

National Harbor

Long Beach

Charlotte 2026

Nashville 2026

Flex CE

Flex Home

Articles

Conference Proceedings

On-demand Webinars

Podcasts

Upcoming Webinars 

Fetch On-Demand

Webinars

Business

Associates

Business & Personal Finance

Buying or Selling a Practice

Career Development

Hospital Design

Leadership & Personal Growth

Owners

Personnel Management

Practice Finances

Practice Managers 

Practice Operations

Students

Technicians 

Technology

Wellbeing & Lifestyle

Partners

Awards

Vet Heroes

Publications

Shop 

Subscribe

May is Arthritis Awareness Month, which is a good time to review our approach to this common diagnosis in small animals.

Raising the standard: Arthritis awareness in veterinary practice

Pet Poison Helpline's recent installment of Toxin Tails shared the story of the Winters family, who all—including their 2 dogs—were diagnosed with ciguatera poisoning.

Toxin for one, toxin for all

From natural disasters to personal setbacks, veterinary professionals need to assess their financial risks, prepare strategically, and take control of their future with a plan that can weather any storm.

When it’s too late to prepare for the unknown and catastrophic

On this episode of The Vet Blast Podcast presented by dvm360, the Caring Pathways team joins Adam Christman, DVM, MBA, to talk all about end-of-life care 

Leveling up end-of-life care: Excellence, compassion, and the future of veterinary hospice

Videos

Asking clients to record videos of their cat at home can play a major role in helping identify pain

Tips for identifying pain in cats

Tatiana Henriques Ferreira, DVM, PhD, MSc, DACVAA, and Marlis Rezende, DVM, PhD, MSc, DACVAA, discuss which types of cases are ideal for inhalant anesthesia vs total intravenous anesthesia.

Cases that use inhalant anesthesia

Practical suggestions for veterinary professionals

Supporting pet owning clients with cancer, and survivors

Elanco Animal Health’s ilunocitinib tablet (Zenrelia) was approved by the FDA in 2024.

Access to canine dermatitis therapy may soon expand to Europe

dvm360 connects veterinarians to essential medical news, veterinary expertise, and insights on pet care products and regulations.

About Us

Fetch DVM360 Conference

Terms and Conditions

Contact Us

Veterinary Podcast

Privacy

Editorial

Do Not Sell My Information

dvm360 - Veterinary News, Veterinarian Pet Care and Medicine Expertise

Facebook

Instagram

LinkedIn

Tiktok

Spotlight

Check out the Fetch On-Demand Catalog

By Role

Practice Manager

Technicians

Subscriptions

dvm360 Newsletter

dvm360 Magazine

1rem

Clinical

The dvm360® pharmacy page is a comprehensive resource for clinical news and insights on the latest veterinary pharmacy. This page consists of articles, videos, interviews that include research on advancements and developments of therapies for veterinary care, and FDA approvals.

#10: What’s going on with xylazine becoming a street drug

On this episode of The Vet Blast Podcast, Kelley Detweiler, a US Drug Enforcement Administration (DEA) and regulatory compliance expert, and Peter Weinstein, DVM, MBA, join host Adam Christman, DVM, MBA, to discuss the emergence of xylazine as a street drug, the implications that has for veterinarians, and what could happen if xylazine were to be declared a controlled substance by the DEA.

We have compiled a countdown of our top Vet Blast Podcast Episodes in 2023, here is number 10

Top Vet Blast Podcast episodes of 2023: #10

Sponsored by Ceva Animal Health, LLC. Head to

and login or create a free CE account and claim your credit after listening to this episode.

In this podcast Dr. Harry Cridge, an ACVIM and ECVIM board-certified specialist in small animal internal medicine, will discuss his approach to the management of pancreatitis in dogs. This podcast will include discussion of Panoquell®-CA1, a novel and innovative solution for neutrophilic inflammation in acute pancreatitis.

Supportive care – intravenous fluids, nutrition, anti-nausea medications, and analgesia

Recall the mechanism of action of Panoquell®-CA1.

Identify potential adverse effects for drugs in the management of pancreatitis.

Develop a treatment plan for a dog with suspected pancreatitis.

PANOQUELL® is a registered trademark of Ishihara Sangyo Kaisha, Ltd.

PANOQUELL®-CA1 is conditionally approved by FDA pending a full demonstration of effectiveness under application number 141 to 567. It is a violation of federal law to use this product other than as directed in the labeling. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

*IMPORTANT SAFETY INFORMATION: The safe use of PANOQUELL®-CA1 has not been evaluated in dogs with cardiac disease, hepatic failure, or renal impairment; dogs that are pregnant, lactating, or intended for breeding; or puppies under 6 months of age. PANOQUELL®-CA1 should not be used in dogs with a known hypersensitivity to fuzapladib sodium. PANOQUELL®-CA1 is a highly protein-bound drug and its use with other highly protein-bound medications has not been studied. The most common adverse effects in the pilot field study were anorexia, digestive tract disorders, respiratory tract disorders, and jaundice. PANOQUELL®-CA1 is not for use in humans. Limited data is available on the potential teratogenic effects of fuzapladib sodium. Therefore, anyone who is pregnant, breastfeeding, or planning to become pregnant should avoid direct contact with PANOQUELL®-CA1. For additional information on the use of PANOQUELL®-CA1, please refer to the package insert.

See prescribing and product information: 

Learn and earn CE credits online with dvm360 Flex

Podcast CE: Panoquell-CA1 and its role in the management of acute pancreatitis

Sponsored by Elanco Animal Health. Head to

There are many barriers, whether real or perceived, to providing preventive care and treating many common ailments in cats. Clients may be wary of seeking wellness care after they've experienced a high stress veterinary visit. Furthermore, they may worry it will be next to impossible to get their cat to comply with any at home preventive or therapeutic medication. What if we could make this experience completely different for both the patient and the client? This presentation will walk you through how to make your wellness visits and prescribed treatments not just better, but enjoyable for your feline patients. Learn tips and tricks from a behaviorist's point of view on how to keep your feline patients content and compliant with all of their wellness care and keep your clients coming back for more.

Feline veterinary visits frequency of care

How to mitigate feline veterinary visit stressors

Identification of fear, anxiety, stress in cats

Environmental strategies to reduce stress

Low-stress techniques for conducting common wellness visit procedures

Strategies to maximize owner success of delivering prescribed preventive care at home

Learn important environmental and handling stress mitigating strategies for feline veterinary visits.

Understand the principles and practices of conditioning positive emotions for your feline patients.

Using feline behavioral knowledge, identify best options and strategies for delivering preventive and therapeutic care to feline patients.

 Credelio CAT kills adult fleas and is indicated for the treatment and prevention of flea infestations (

) for one month in cats and kittens 8 weeks of age and older and weighing 2.0 pounds or greater. Credelio CAT is also indicated for treatment and control of 

 (black-legged tick) infestations for one month in cats and kittens 6 months of age and older and weighing 2.0 pounds or greater.

 Lotilaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia and seizures. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders. The safety of Credelio CAT has not been established in breeding, pregnant and lactating cats. The effectiveness of Credelio CAT against 

 in kittens less than 6 months of age has not been evaluated. The most frequently reported adverse reactions are weight loss, tachypnea and vomiting. For full prescribing information see Credelio CAT 

Podcast CE: Breaking down behavioral barriers to feline wellness care 

Due in large part to the COVID-19 pandemic, the world has embraced virtual care and telemedicine more than ever before. Jessica Lowe, DVM, MBA, BSc, joins The Vet Blast Podcast to share her experiences with virtual care and how it continues to evolve.

Below is a partial transcript. Listen to the full podcast for more.

: Right now, there's about a two-to-three month waiting period between us getting into a doctor in an in-clinic setting. If the dog has had a little bit of loose bowels, we can talk to them before sending them to you. We can even send them a fecal kit to get their fecal ahead of time...Now you just have to prescribe your dewormer and you're done. You know, we're here to assist and complement the in-person clinic.

How virtual care is changing the landscape of veterinary medicine

Moving the needle in vet med with telehealth and virtual care

On the latest episode of The Vet Blast Podcast, host Adam Christman, DVM, MBA explores the emerging world of electronic prescribing with Elliot Garber, DVM, MPH, MS, DACVPM. They discuss how this can affect workflow and why it has taken so long for this process to make the jump from human to veterinary medicine.

: If you're going to be losing those sales anyway, you don't want to then have to pay your staff to sort through both the fax machine and 5 different online portals from different pharmacies to check the medical records [to] make sure...[it] is a valid prescription. Then, go in and approve it or fax it back or get on the phone to the retail pharmacy and try to reach the pharmacist who can actually talk to you to approve a prescription. So, it's kind of a double burn for the veterinary teams, because not only are they losing the sale of that prescription product, but then they have to lose a bunch of their time dealing with that in an inefficient way too.

Electronic prescribing finally comes to veterinary medicine

How e-prescribing can save time and enhance patient safety

The latest canine otitis externa medication is the only FDA-approved, 1-dose, in-clinic treatment for Pseudomonas aeruginosa and other pathogens.

FDA approves Mometamax Single

Royal Canin is highlighting the importance of a personalized health plan based on each pets' unique needs with these products and designated day for awareness

National Pet Wellness Day is launched with new line of supplements and probiotics

Dechra’s Otiserene is a single-dose, long-acting product that utilizes marbofloxacin

FDA approves new canine otitis externa medication

Visible particulate matter was observed in 2 products containing dexmedetomidine hydrochloride injection 0.5 mg/mL for dogs and cats.

Prescription sedative and analgesic is voluntarily recalled

Tatiana Henriques Ferreira, DVM, PhD, MSc, DACVAA, and Marlis Rezende, DVM, PhD, MSc, DACVAA, discuss best practices

Understanding when to use inhalant anesthesia

Tatiana Henriques Ferreira, DVM, PhD, MSc, DACVAA, a clinical assistant professor at the University of Wisconsin-Madison School of Veterinary Medicine, and Marlis Rezende, DVM, PhD, MSc, DACVAA, an associate professor of anesthesia and analgesia at Colorado State University College of Veterinary Medicine and Biological Sciences in Fort Collins, co-presented a lecture on inhalant anesthesia vs total intravenous anesthesia (TIVA) at the 2025 North American Veterinary Community 

 interview, they discussed cases that commonly use inhalant anesthesia.

Using total intravenous anesthesia in certain cases

The following is a transcript of the video

Tatiana Henriques Ferreira, DVM, PhD, MSc, DACVAA

: You really can do inhalant anesthesia for any procedure, but you just have to keep in mind that inhalant anesthetics can lead to some negative effects on some body systems. And in the example of the neuro patients, when you worry about intracranial pressure, you could think about mitigating some of those negative effects by keeping the inhaling anesthetics low, like below Mac values. And this would mitigate some of those side effects.

: And controlling CO2, so that’ the same thing.

 Perhaps a little bit more aggressive in the case of inhalants, then you have to be with TIVA. But yeah, we can do those two.

Pharmacology

Latest News